Medicare beneficiaries face confusion in selecting plans, with 75% finding the process challenging and many unaware of ...

Telehealth and home care services face potential disruptions, impacting rural and mobility-limited patients, with possible ...

An expert discusses how current ITP treatments like corticosteroids, rituximab, and fostamatinib have significant tolerability issues and fail to provide sustained platelet responses or address ...

An expert discusses how rilzabrutinib, a recently FDA-approved Bruton tyrosine kinase inhibitor, targets the autoimmune pathophysiology of ITP by modulating B cells, macrophages, and reducing ...

At the European Respiratory Society Congress 2025, Lucilla Piccari, MD, PhD, a pulmonologist at Hospital del Mar in Barcelona, Spain, discussed the profound impact of social inequality, environmental ...

Blood-based biomarkers, including neutrophil-to-lymphocyte ratio and circulating tumor DNA, may improve treatment response ...

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.

Primary aldosteronism is often overlooked in hypertension. Educating providers and utilizing tools can enhance screening and treatment effectiveness, emphasizes Vivek Bhalla, MD, Stanford.

Compared with SNRA, SPRA was linked to a 29% higher risk of pneumonia and a 58% higher risk of hospitalization. Researchers noted that seropositivity may reflect greater systemic inflammation and ...